Skip to main content

MoneyWorks4Me

Lupin informs about board meeting

25 Jan 2023 Evaluate

Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Lupin has informed that a meeting of the Board of Directors of the Company will be held on February 9, 2023, to consider and take on record unaudited financial results of the Company for the quarter and nine-months ended December 31, 2022.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..